. (C) Expression of iNOS and COX-2 with DDF. Cells were cultured for 24 h with LPS (250 ng/mL), fixed, permeabilized, and incubated with rabbit polyclonal anti-iNOS antibody, followed by Alexa-488-conjugated anti-rabbit Ig (green); and with mouse polyclonal anti-COX-2 antibody followed by Alexa-594-conjugated anti-mouse Ig (red); The nuclei of the corresponding cells were visualized by DAPI staining (blue). Normal, untreated control cells; LPS, treatment with only LPS (250 ng/mL); DDF, 6.8-diprenyl-4′,7-dihydroxyflavanone; (magnification: 60×, scale bars: 50 μm). Cells were cultured for 24 h with LPS (250 ng/mL), fixed, permeabilized, and incubated with rabbit polyclonal anti-iNOS antibody, followed by Alexa-488-conjugated anti-rabbit Ig (green); and with mouse polyclonal anti-COX-2 antibody followed by Alexa-594-conjugated anti-mouse Ig (red); The nuclei of the corresponding cells were visualized by DAPI staining (blue). Normal, untreated control cells; LPS, treatment with only LPS (250 ng/mL); DDF, 6.8-diprenyl-4 ,7-dihydroxyflavanone; (magnification: 60×, scale bars: 50 µm).
